Skip to main content
SpringerLink
Log in

Fatigue in Primary Sjögren’s Syndrome

  • Chapter
  • First Online:
Sjögren’s Syndrome

Abstract

Recognition of a syndrome characterized by fatigue in patients without an obvious cardiopulmonary illness dates back to the late nineteenth century [1–3]. Early descriptions of patients with “neurasthenia” focused on the substantial weakness and lassitude accompanying the syndrome, which was particularly prominent among women. Following the conclusion of the First World War, physicians were challenged by the large numbers of battle-scarred veterans afflicted by chronic fatigue [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beard GM. Neurosthenia, or nervous exhaustion. Boston Med Surg J. 1869;3:217–20.

    Google Scholar 

  2. Shorter E. Chronic fatigue in historical perspective. Ciba Found Symp. 1993;173:6–16.

    PubMed  CAS  Google Scholar 

  3. Wessely S. Old wine in new bottles: neurasthenia and “M.E.”. Psychol Med. 1990;20:427–36.

    Google Scholar 

  4. Muscio B. Is a fatigue test possible? Br J Psychol. 1921;12:31–46.

    Google Scholar 

  5. Chen MK. The epidemiology of self-perceived fatigue among adults. Prev Med. 1986;15:74–81.

    PubMed  CAS  Google Scholar 

  6. Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998;45:53–65.

    PubMed  CAS  Google Scholar 

  7. Wolfe F, Michaud K, Li T, Katz RS. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol. 2010;37:296–304.

    PubMed  Google Scholar 

  8. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3.

    PubMed  CAS  Google Scholar 

  9. Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32:811–9.

    PubMed  Google Scholar 

  10. Tiesinga LJ, Dassen TW, Halfens RJ. DUFS and DEFS: development, reliability and validity of the Dutch fatigue scale and the Dutch exertion fatigue scale. Int J Nurs Stud. 1998;35:115–23.

    PubMed  CAS  Google Scholar 

  11. Bowman SJ, Booth DA, Platts RG, UK Sjogren’s Interest Group. Measurement of fatigue and discomfort in primary Sjogren’s syndrome using a new questionnaire tool. Rheumatology. 2004;43:758–64.

    PubMed  CAS  Google Scholar 

  12. Meijer JM, Meiners PM, Vissink A, et al. Effective rituximab treatment in primary Sjogren’s syndrome: a randomised, double-blind, placebo-controlled trial. Arthritis Rheum. 2010. doi:10.1002/art.27314.

  13. Virkki LM, Porola P, Forsblad-d’Elia H, Valtysdottir S, Solovieva SA, Konttinen YT. Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjögren’s syndrome. Arthritis Care Res. 2010;62:118–24.

    CAS  Google Scholar 

  14. d’Elia HF, Bjurman C, Rehnberg E, Kvist G, Konttinen YT. Interleukin 6 and its soluble receptor in a central role at the neuroimmunoendocrine interface in Sjogren syndrome: an explanatory interventional study. Ann Rheum Dis. 2009;68:285–6.

    PubMed  Google Scholar 

  15. Goodchild CE, Treharne GJ, Booth DA, Kitas GD, Bowman SJ. Measuring fatigue among women with Sjogren’s syndrome or rheumatoid arthritis: a comparison of the Profile of Fatigue (ProF) and the Multidimensional Fatigue Inventory (MFI). Musculoskeletal Care. 2008;6:31–48.

    PubMed  CAS  Google Scholar 

  16. Vriezekolk JE, Geenen R, Hartkamp A, et al. Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjogren’s syndrome. J Rheumatol. 2005;32:2351–5.

    PubMed  Google Scholar 

  17. Hartkamp A, Geenen R, Bijl M, Kruize AA, Godaert GL, Derksen RH. Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren’s syndrome. Ann Rheum Dis. 2004;63:1335–7.

    PubMed  CAS  Google Scholar 

  18. Zandbelt MM, de Wilde P, van Damme P, et al. Etancercept in the treatment of patients with primary Sjogren’s syndrome: a pilot study. J Rheumatol. 2004;31:96–101.

    PubMed  CAS  Google Scholar 

  19. Godaert GL, Hartkamp A, Geenen R, et al. Fatigue in daily life in patients with primary Sjogren’s syndrome and systemic lupus erythematosus. Ann N Y Acad Sci. 2002;966:320–6.

    PubMed  CAS  Google Scholar 

  20. Barendregt PJ, Visser MR, Smets EM, et al. Fatigue in primary Sjogren’s syndrome. Ann Rheum Dis. 1998;57:291–5.

    PubMed  CAS  Google Scholar 

  21. Harboe E, Beyer MK, Greve OJ, et al. Cerebral white matter hyperintensities are not increased in patients with primary Sjogren’s syndrome. Eur J Neurol. 2009;16:576–81.

    PubMed  CAS  Google Scholar 

  22. Segal B, Thomas W, Rogers T, et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjogren’s syndrome. Arthritis Rheum. 2008;59:1780–7.

    PubMed  Google Scholar 

  23. Segal B, Bowman SJ, Fox PC, et al. Primary Sjogren’s syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;7:46.

    PubMed  Google Scholar 

  24. Walker J, Gordon T, Lester S, et al. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjogren’s syndrome. J Rheumatol. 2003;30:2406–12.

    PubMed  Google Scholar 

  25. Bax HI, Vriesendorp TM, Kallenberg CGM, Kalk WWI. Fatigue and immune activity in Sjögren’s syndrome. Ann Rheum Dis. 2002;61:284.

    PubMed  CAS  Google Scholar 

  26. Reeves WC, Lloyd A, Vernon SD, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res. 2003;3:25.

    PubMed  Google Scholar 

  27. Champey J, Corruble E, Gottenberg JE, et al. Quality of life and psychological status in patients with primary Sjogren’s syndrome and sicca symptoms without autoimmune features. Arthritis Rheum. 2006;55:451–7.

    PubMed  Google Scholar 

  28. Belanguer R, Ramos-Casals M, Brito-Zeron P, et al. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2005;23:351–6.

    Google Scholar 

  29. Rostron J, Rogers S, Longman L, et al. Health-related quality of life in patients with primary Sjogren’s syndrome and xerostomia: a comparative study. Gerondontology. 2002;10:53–9.

    Google Scholar 

  30. Tensing EK, Solovieva SA, Tervahartiala T, et al. Fatigue and health profile in sicca syndrome of Sjogren’s and non-Sjogren’s syndrome origin. Clin Exp Rheumatol. 2001;19:313–6.

    PubMed  CAS  Google Scholar 

  31. Strombeck B, Ekdahl C, Manthorpe R, Wikstrom I, Jacobsson L. Health-related quality of life in primary Sjogren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol. 2000;29:283–8.

    Google Scholar 

  32. Thomas E, Hay EM, Hajeer A, et al. Sjogren’s syndrome: a community-based study of prevalence and impact. Br J Rheumatol. 1998;37:1069–76.

    PubMed  CAS  Google Scholar 

  33. Khanna D, Pope JE, Khanna PP, et al. The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice. J Rheumatol. 2008;35:2339–43.

    PubMed  Google Scholar 

  34. Theander L, Strombeck B, Mandl T, et al. Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjogren’s syndrome? Rheumatology (Oxford). 2010;49:1177–83.

    Google Scholar 

  35. Goodchild CE, Treharne GJ, Booth DA, Bowman SJ. Daytime patterning of fatigue and its associations with the previous night’s discomfort and poor sleep among women with primary Sjögren’s syndrome or rheumatoid arthritis. Musculoskeletal Care. 2010;8(2):107–17. PMID: 20229610.

    PubMed  CAS  Google Scholar 

  36. Mandl T, Hammar O, Theander E, Wollmer P, Ohlsson B. Autonomic nervous dysfunction development in patients with primary Sjogren’s syndrome: a follow-up study. Rheumatology (Oxford). 2010;49(6):1101–6.

    Google Scholar 

  37. Bowman SJ, Hamburger J, Richards A, et al. Patient-reported outcomes in primary Sjogren’s syndrome: comparison of the long and short versions of the profile of fatigue and discomfort–sicca symptoms inventory. Rheumatology (Oxford). 2009;48:140–3.

    CAS  Google Scholar 

  38. Bowman SJ, Sutcliffe N, Isenberg DA, et al. Sjögren’s Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren’s syndrome. Rheumatology (Oxford). 2007;461:845–51.

    Google Scholar 

  39. Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validity of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31:1601–7.

    PubMed  Google Scholar 

  40. Lwin CT, Bishay M, Platts RG, Booth DA, Bowman SJ. The assessment of fatigue in primary Sjögren’s syndrome. Scand J Rheumatol. 2003;32:33–7.

    PubMed  Google Scholar 

  41. Strombeck B, Ekdahl C, Manthorpe R, Jacobsson LT. Physical capacity in women with primary Sjogren’s syndrome: a controlled study. Arthritis Rheum. 2003;49:681–8.

    PubMed  Google Scholar 

  42. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147–53.

    PubMed  CAS  Google Scholar 

  43. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue. Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum. 2007;57:1348–57.

    Google Scholar 

  44. Goligher EC, Pouchot J, Brant R, et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol. 2008;35:635–42.

    PubMed  Google Scholar 

  45. Pouchot J, Kherani RB, Brant R, et al. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol. 2008;61:705–13.

    PubMed  Google Scholar 

  46. Smets EMA, Garssen B, Bonke B, De Haes JCJM. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25.

    PubMed  CAS  Google Scholar 

  47. Krupp LB, LaRocca NG, Muir J, Steinberg AD. A study of fatigue in systemic lupus erythematosus. J Rheumatol. 1990;17:1450–2.

    PubMed  CAS  Google Scholar 

  48. Cauch-Dudek K, Abbey S, Steward DE, Heathcote EJ. Fatigue in primary biliary cirrhosis. Gut. 1998;43:705–10.

    PubMed  CAS  Google Scholar 

  49. Flachenecker P, Kumpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler. 2002;8:523–6.

    PubMed  CAS  Google Scholar 

  50. Kleinman L, Zodet MW, Hakim Z, et al. Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res. 2000;9:499–508.

    PubMed  CAS  Google Scholar 

  51. Keyser RE, Rus V, Cade WT, Kalappa N, Flores RH, Handwerger BS. Evidence for aerobic insufficiency in women with systemic lupus erythematosus. Arthritis Rheum. 2003;49:16–22.

    PubMed  Google Scholar 

  52. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996;23:1407–17.

    PubMed  CAS  Google Scholar 

  53. Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol. 2005;32:1699–705.

    PubMed  Google Scholar 

  54. van der Werf SP, Evers A, Jongen PJ, Bleijenberg G. The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis. Mult Scler. 2003;9:89–94.

    PubMed  Google Scholar 

  55. Burgos PI, Alarcón GS, McGwin GJ, Crews KQ, Reveille JD, Vilá LM. Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum. 2009;61:1179–86.

    PubMed  Google Scholar 

  56. Omdal R, Waterloo L, Koldingsnes W, Husby G, Mellgen SI. Fatigue in patients with systemic lupus erythematosus; the psychosocial aspects. J Rheumatol. 2003;30:283–7.

    PubMed  Google Scholar 

  57. Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity. J Rheumatol. 1998;25:892–5.

    PubMed  CAS  Google Scholar 

  58. Zonana-Nacach A, Roseman JM, McGwin Jr G, et al. Systemic lupus erythematosus in three ethnic groups. VI: factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. Lupus in minority populations: nature vs nurture. Lupus. 2000;9:101–9.

    PubMed  CAS  Google Scholar 

  59. Kant IJ, Bültmann U, Schröer KA, Beurskens AJ, van Amelsvoort LG, Swaen GM. An epidemiological approach to study fatigue in the working population: the Maastricht Cohort Study. Occup Environ Med. 2003;60(Suppl I):i32–9.

    PubMed  Google Scholar 

  60. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey(SF-36): conceptual framework and item selection. Med Care. 1992;30:473–83.

    PubMed  Google Scholar 

  61. Anderson JJ, Ruwe M, Miller DR, Kazis L, Felson DT, Prashker M. Relative costs and effectiveness of specialist and general internist ambulatory care for patients with 2 chronic musculoskeletal conditions. J Rheumatol. 2002;29:1488–95.

    PubMed  Google Scholar 

  62. Komaroff AL, Fagioli LR, Doolittle TH, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med. 1996;101:281–90.

    PubMed  CAS  Google Scholar 

  63. Fox PC, Bowman SJ, Segal B, et al. Oral involvement in primary Sjogren syndrome. J Am Dent Assoc. 2008;139:1592–601.

    PubMed  Google Scholar 

  64. Wolfe F, Michaud K. Prevalence, risk, and risk factors for oral and ocular dryness with particular emphasis on rheumatoid arthritis. J Rheumatol. 2008;35:1023–30.

    PubMed  Google Scholar 

  65. Wolfe F, Michaud K. Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity. Arthritis Rheum. 2009;61:667–73.

    PubMed  Google Scholar 

  66. Segal BM, Pogatchnik B, Holker E, et al. Primary Sjogren’s syndrome: cognitive symptoms, mood and cognitive performance. Acta Neurol Scand. 2011. doi:10.1111/j.1600-0404.2011.01530x.

  67. Le Guern V, Belin C, Henegar C, et al. Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren’s syndrome: a case-control study. Ann Rheum Dis. 2010;69:132–7.

    PubMed  Google Scholar 

  68. Segal B, Mueller B, Zhu X, et al. Disruption of brain white matter microstructure in primary Sjogren’s syndrome: evidence from diffusion tensor imaging. Rheumatology (Oxford). 2010;49(8):1530–9.

    Google Scholar 

  69. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology. 2010;35:192–216.

    PubMed  Google Scholar 

  70. Arnsten FT. Stress signaling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009;10:410–20.

    PubMed  CAS  Google Scholar 

  71. Dolcos F, Kragel P, Wang L, McCarthy G. Role of the inferior frontal cortex in coping with distracting emotions. Neuroreport. 2006;17:1591–4.

    PubMed  Google Scholar 

  72. Harboe E, Tjensvoll AB, Vefring HK, Goransson LG, Kvaloy JT, Omdal R. Fatigue in primary Sjogren’s syndrome – a link to sickness behaviour in animals? Brain Behav Immun. 2009;23:1104–8.

    PubMed  CAS  Google Scholar 

  73. Sepulcre J, Masdeu JC, Goni J, et al. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult Scler. 2009;15:337–44.

    PubMed  CAS  Google Scholar 

  74. Harboe E, Greve OJ, Beyer M, et al. Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 2008;79:199–201.

    PubMed  CAS  Google Scholar 

  75. Rocca MA, Agosta F, Colombo B, et al. FMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFN beta-1a injection. Hum Brain Mapp. 2007;28:373–82.

    PubMed  Google Scholar 

  76. DeLuca J, Genova HM, Hillary FG, Wylie G. Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI. J Neurol Sci. 2008;270:28–39.

    PubMed  Google Scholar 

  77. Inglese M, Park S, Johnson G, et al. Deep gray matter perfusion in multiple sclerosis dynamic susceptibility contrast perfusion magnetic resonance imaging at 3T. Arch Neurol. 2007;64:196–202.

    PubMed  Google Scholar 

  78. Tartaglia MC, Narayanan S, Francis S, et al. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol. 2004;61:201–7.

    PubMed  Google Scholar 

  79. Segal B, Mueller BA, Pogatchnik BP, et al. Abnormalities in cerebral white matter microstructure correlate with cognitive function and psychological symptoms in patients with primary Sjogren’s syndrome. Presented at the 10th international Sjogren’s syndrome congress. Brest, France; 2009.

    Google Scholar 

  80. Tench C, Bentley D, Vleck V, McCurdie I, White P, D’Cruz D. Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol. 2002;29:474–81.

    PubMed  Google Scholar 

  81. Gudbjornsson B, Broman JE, Hetta J, Halgren R. Sleep disturbances in patients with primary Sjogren’s syndrome. Br J Rheumatol. 1993;32:1072–6.

    PubMed  CAS  Google Scholar 

  82. Tishler M, Barak Y, Paran D, Yaron M. Sleep disturbances, fibromyalgia and primary Sjogren’s syndrome. Clin Exp Rheumatol. 1997;15:71–4.

    PubMed  CAS  Google Scholar 

  83. Chandrasekhara PK, Jayachandran NV, Rajasekhar L, Thomas J, Narsimulu G. The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol. 2009;19:407–15.

    PubMed  Google Scholar 

  84. Tench CM, McCurdie I, White PD, D’Cruz DP. The prevalence and associations of fatigue in systemic erythematosus. Rheumatology (Oxford). 2000;39:1249–54.

    CAS  Google Scholar 

  85. Buysse DJ, Reynolds 3rd CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.

    PubMed  CAS  Google Scholar 

  86. Lichstein KL, Stone KC, Donaldson J, et al. Actigraphy validation with insomnia. Sleep. 2006;29:232–9.

    PubMed  Google Scholar 

  87. Kapsimalis F, Basta M, Varouchakis G, Gourgoulianis K, Vgontzas A, Kryger M. Cytokines and pathological sleep. Sleep Med. 2008;9:603–14.

    PubMed  Google Scholar 

  88. Johnson EO, Kostandi M, Moutsopoulos HM. Hypothalamic-pituitary-adrenal axis function in Sjogren’s syndrome: mechanisms of neuroendocrine and immune system homeostasis. Ann N Y Acad Sci. 2006;1088:41–51.

    PubMed  CAS  Google Scholar 

  89. Mandl T, Jacobsson L, Lilja B, Sundkvist G, Manthorpe R. Disturbances of autonomic nervous function in primary Sjogren’s syndrome. Scand J Rheumatol. 1997;26:401–6.

    PubMed  CAS  Google Scholar 

  90. Kovacs L, Paprika D, Takacs R, et al. Cardiovascular autonomic dysfunction in primary Sjogren’s syndrome. Rheumatology (Oxford). 2004;43:95–9.

    Google Scholar 

  91. Barendregt PJ, Tulen JHM, van den Meiracker AH, Markusse HM. Spectral analysis of heart rate and blood pressure variability in primary Sjögren’s syndrome. Ann Rheum Dis. 2002;61:232–6.

    PubMed  CAS  Google Scholar 

  92. d’Elia HF, Rehnberg E, Kvist G, Ericsson A, Konttinen Y, Mannerkorpi K. Fatigue and blood pressure in primary Sjogren’s syndrome. Scand J Rheumatol. 2008;37:284–92.

    PubMed  Google Scholar 

  93. Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002;25:154–9.

    PubMed  CAS  Google Scholar 

  94. Kelly KW, Bluthe R, Dantzer R, et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003;17:112–8.

    Google Scholar 

  95. Rothwell NJ. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol Sci. 1991;12:43–436.

    Google Scholar 

  96. Santos RV, Tufik S, De Mello MT. Exercise, sleep and cytokines: is there a relation? Sleep Med Rev. 2007;11:231–9.

    PubMed  CAS  Google Scholar 

  97. Valtysdottir ST, Wide L, Hallgren R. Mental wellbeing and quality of sexual life in women with primary Sjogren’s syndrome are related to circulating dehydroepiandrosterone sulphate. Ann Rheum Dis. 2003;62:875–9.

    PubMed  Google Scholar 

  98. Valtysdottir ST, Wide L, Hallgren R. Low serum dehydroepiandrosterone sulfate in women with primary Sjogren’s syndrome as an isolated sign of impaired HPA axis function. J Rheumatol. 2001;28:1259–65.

    PubMed  CAS  Google Scholar 

  99. Hartkamp A, Geenen R, Godaert GL, et al. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial. Ann Rheum Dis. 2008;67:91–7.

    PubMed  CAS  Google Scholar 

  100. Porola P, Virkki L, Przybyla BD, et al. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjogren’s syndrome. J Rheumatol. 2008;35:2229–35.

    PubMed  CAS  Google Scholar 

  101. Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardier C, Goldenberg DL. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160–72.

    PubMed  CAS  Google Scholar 

  102. Bennett RM. Fibromyalgia: the commonest cause of widespread pain. Compr Ther. 1995;21:69–75.

    Google Scholar 

  103. Lorentzen F. Fibromyalgia: a clinical challenge. J Intern Med. 1994;235:199–203.

    Google Scholar 

  104. Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006;67:1219–25.

    PubMed  Google Scholar 

  105. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med. 2004;66:837–44.

    PubMed  Google Scholar 

  106. Wolfe F, Petri M, Alarcon GS, et al. Fibromyalgia, SLE and evaluation of SLE disease activity. J Rheumatol. 2009;36:82–8.

    PubMed  Google Scholar 

  107. Wolfe F. Fibromyalgianess. Arthritis Rheum. 2009;61:715–6.

    PubMed  Google Scholar 

  108. Ostuni P, Botsios C, Sfriso P, et al. Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren’s syndrome. Minerva Med. 2002;93:203.

    PubMed  CAS  Google Scholar 

  109. Giles I, Isenberg D. Fatigue in primary Sjogren’s syndrome: is there a link with the fibromyalgia syndrome? Ann Rheum Dis. 2000;59:875–8.

    PubMed  CAS  Google Scholar 

  110. McBeth J, Silman AJ, Gupta A, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread pain. Arthritis Rheum. 2007;56:360–71.

    PubMed  CAS  Google Scholar 

  111. Staud R. Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res Ther. 2006;8:208.

    PubMed  Google Scholar 

  112. Van Houdenhove B. Central sensitivity syndromes: stress system failure may explain the whole picture. Semin Arthritis Rheum. 2009;39:218–9.

    PubMed  Google Scholar 

  113. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing fibromyalgia. Arthritis Rheum. 2002;46:1333–43.

    PubMed  Google Scholar 

  114. Segal B, Bowman SJ, Fox PC, et al. Prevalence of sensory symptoms in primary Sjogren’s Syndrome (pSS) and relationship of neuropathic symptoms to depression and fibromyalgia. Arthritis Rheum. 2007;56(Supple):S448.

    Google Scholar 

  115. Giske L, Bautz-Holter E, Sandvik L, Roe C. Relationship between pain and neuropathic symptoms in chronic musculoskeletal pain. Pain Med. 2009;10:910–7.

    PubMed  CAS  Google Scholar 

  116. Bjerrum K, Prause J. Primary Sjogren’s syndrome: a subjective description of the disease. Clin Exp Rheumatol. 1990;8:283–8.

    PubMed  CAS  Google Scholar 

  117. Al-Allaf AW, Ottewell L, Pullar T. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2–4 years’ follow-up. Clin Rheumatol. 2002;21:472–7.

    PubMed  CAS  Google Scholar 

  118. Rhodus NL, Fricton J, Carlson P, Messner R. Oral symptoms associated with fibromyalgia. J Rheumatol. 2003;30:1841–5.

    PubMed  Google Scholar 

  119. Lopate G, Pestronk A, Al-Lozi M, et al. Peripheral neuropathy in an outpatient cohort of patients with Sjogren’s syndrome. Muscle Nerve. 2006;33:672–6.

    PubMed  Google Scholar 

  120. Batbayar B, Nagy G, Kovesi G, Zelles T, Feher E. Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjogren’s syndrome. Arch Oral Biol. 2004;49:529–38.

    PubMed  CAS  Google Scholar 

  121. Staud R. Pharmacological treatment of fibromyalgia syndrome: new developments. Drugs. 2010;70:1–14.

    PubMed  CAS  Google Scholar 

  122. Neill J, Belan I, Ried K. Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. J Adv Nurs. 2006;56:617–35.

    PubMed  Google Scholar 

  123. Dass S, Bowman SJ, Vital EM, et al. Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis. 2008;67:1541–4.

    PubMed  CAS  Google Scholar 

  124. Meijer JM, Pijpe J, Vissink A, Kallenberg CG, Bootsma H. Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment. Ann Rheum Dis. 2009;68:284–5.

    PubMed  CAS  Google Scholar 

  125. Karlson EW, Liang MH, Eaton H, et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum. 2004;50:1832–41.

    PubMed  Google Scholar 

  126. Strombeck BE, Theander E, Jacobsson LT. Effects of exercise on aerobic capacity and fatigue in women with primary Sjogren’s syndrome. Rheumatology (Oxford). 2007;46:868–71.

    CAS  Google Scholar 

  127. Strömbeck B, Theander E, Jacobsson LT. Assessment of fatigue in primary Sjögren’s syndrome: the Swedish version of the Profile of Fatigue. Scand J Rheumatol. 2005;34:455–9.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatic and Autoimmune Disorders, University of Minnesota Medical School, Minneapolis, MN, USA

    Barbara M. Segal

  2. Department of Medicine, Hennepin County Medical Center, Minneapolis, MN, USA

    Barbara M. Segal

Authors
  1. Barbara M. Segal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Barcelona, Surgey, Hospital Clinic, Calle Villarroel, 170, Barcelona, 08036, Spain

    Manuel Ramos-Casals

  2. Massachusetts General Hospital, Boston, 02114, Massachusetts, USA

    John H. Stone

  3. National University of Athens, Athens, Greece

    Haralampos M. Moutsopoulos

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Segal, B.M. (2011). Fatigue in Primary Sjögren’s Syndrome. In: Ramos-Casals, M., Stone, J., Moutsopoulos, H. (eds) Sjögren’s Syndrome. Springer, London. https://doi.org/10.1007/978-0-85729-947-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-947-5_9

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-946-8

  • Online ISBN: 978-0-85729-947-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation